
News
Filter Results
Displaying 1–10 of 506
-
Apr 11, 2025
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmentosa.
-
Apr 11, 2025
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Apr 11, 2025
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis
-
Apr 11, 2025
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Apr 11, 2025
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
-
Apr 10, 2025
The partnership will formalize an ongoing commitment by both companies to accelerate the development of treatments and cures for retinal diseases, while prioritizing a patient-centric approach.
-
Apr 7, 2025
Atsena Receives $150 Million in New Financing to Advance XLRS and Preclinical Gene Therapy Programs
The company has reported encouraging results from its LCA1 and XLRS gene therapy clinical trials.
-
Mar 13, 2025
Honoring the Legacy of Bob Reintsma: A Visionary in the Fight Against Blinding Diseases
Bob Reintsma was fiercely passionate about driving treatments and cures for blinding diseases for most of his life. The Foundation is extremely grateful for Bob’s dedication to our mission and legacy of generosity.
-
Mar 11, 2025
Luxa Reports Vision Improvements in Clinical Trial of its RPE Stem Cell Therapy for Dry AMD
Patients with worse vision at trial enrollment had greatest vision improvements.
-
Mar 7, 2025
Neurotech’s Encapsulated Cell Technology Receives FDA Approval for Treatment of MacTel
The technology was previously funded by the Foundation for the treatment of retinitis pigmentosa and dry age-related macular degeneration.